D-1144-2023 Class III Terminated

Recalled by Caplin Steriles Limited — Gummidipoondi, N/A

FDA drug recall D-1144-2023 was initiated by Caplin Steriles Limited on Aug 14, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 9, 2025). Affected quantity: 19, 820 vials.

Recall details

Product Type
Drugs
Report Date
Sep 13, 2023
Initiation Date
Aug 14, 2023
Termination Date
Sep 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19, 820 vials

Product description

Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDC 72485-502-01 (single vial), Rx only, Distributed by: Armas Pharmaceuticals, Inc. Freehold, NJ 07728(USA) Manufactured by: Caplin Steriles Limited, India, NDC 72485-502-10

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide in Tennessee

Code information

Lot #: 90000228

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1144-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1144-2023. Report a data issue: hello@regdatalab.com.